Patent · US Active

Fusion proteins and combination vaccines comprising haemophilus influenzae Protein E and Pilin A

US10730917B2 · kind B2 · utility

1Cited by

9References

5Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Normand Blais · Laval, CA
Steve Labbe · Laval, CA
Jan Poolman · Broek in Waterland, NL

Key dates

Filing date	Jan 4, 2018
Grant date	Aug 4, 2020
Priority date	—
Expiry date	Jan 4, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising Haemophilus influenzae Protein E and Pilin A. More particularly, the present application relates to fusion proteins and immunogenic compositions comprising Protein E and PilA, vaccines comprising such immunogenic compositions and therapeutic uses of the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.